Evidence map›Paper›PMID 31813161›Full record

ArticleBiometrics2020

Joint analysis of single-cell and bulk tissue sequencing data to infer intratumor heterogeneity.

Wei Sun, Chong Jin, Jonathan A Gelfond, Ming-Hui Chen, Joseph G Ibrahim

Abstract read
In one paragraph

Article in Biometrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei SunPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0002-6350-1107
Chong JinDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Jonathan A GelfondDepartment of Epidemiology and Biostatistics, UT Health Science Center, San Antonio, Texas.
Ming-Hui ChenDepartment of Statistics, University of Connecticut, Storrs, Connecticut.ORCID 0000-0003-1935-2447
Joseph G IbrahimDepartment of Biostatistics, University of North Carolina, Chapel Hill, North Carolina.

Funding

Statistical Methods for RNA-seq Data AnalysisR01GM105785 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Wei Sun · 2014 to 2026
$4.6M
Statistical Methods for Analysis of Tumor Heterogeneity in Genetic EpidemiologyR01CA189532 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HSU, LI · 2015 to 2023
$4.2M
Bayesian Approaches to Model Selection for Survival DataR01GM070335 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI IBRAHIM, JOSEPH G · 2003 to 2019
$4.0M
Estimation and association analysis of biomarkers for tumor immune microenvironmentR21CA224026 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SUN, WEI · 2018 to 2019
$415k
NCI NIH HHS R01 CA189532NCI NIH HHS R21 CA224026NIGMS NIH HHS R01 GM070335NIGMS NIH HHS R01 GM105785
6 · The paper itself

Abstract

Many computational methods have been developed to discern intratumor heterogeneity (ITH) using DNA sequence data from bulk tumor samples. These methods share an assumption that two mutations arise from the same subclone if they have similar mutant allele-frequencies (MAFs), and thus it is difficult or impossible to distinguish two subclones with similar MAFs. Single-cell DNA sequencing (scDNA-seq) data can be very informative for ITH inference. However, due to the difficulty of DNA amplification, scDNA-seq data are often very noisy. A promising new study design is to collect both bulk and single-cell DNA-seq data and jointly analyze them to mitigate the limitations of each data type. To address the analytic challenges of this new study design, we propose a computational method named BaSiC (Bulk tumor and Single Cell), to discern ITH by jointly analyzing DNA-seq data from bulk tumor and single cells. We demonstrate that BaSiC has comparable or better performance than the methods using either data type. We further evaluate BaSiC using bulk tumor and single-cell DNA-seq data from a breast cancer patient and several leukemia patients.

Indexed as

NeoplasmsGenetic HeterogeneityHumansMutationSequence Analysis, DNAbulk tumor samplesintratumor heterogeneitymissing mutation callssingle-cell DNA sequencing

Identifiers

PMID31813161
PMCPMC7275921

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.